Clinical Trial Update: A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating HB-Vac Activated-DCs with Peg-IFN or nucleos(t)ide analogues in chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HB-Vac Activated-DCs
• NAs
• PEG-IFNα (pegylated interferon alfa)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Chronic Hepatitis B | Phase 1, Phase 2 | Status: COMPLETED